Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ischemic stroke

S E Kasner1, J C Grotta

  • 1Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. kasner@mail.med.upenn.edu

Neurologic Clinics
|May 13, 1998
PubMed
Summary
This summary is machine-generated.

Rapid intervention is crucial for acute ischemic stroke. Stroke protocols and therapies like thrombolysis, initiated within 3 hours, significantly improve outcomes, alongside emerging reperfusion and neuroprotection strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulse pressure variability is associated with unfavorable outcomes in acute ischaemic stroke patients treated with intravenous thrombolysis.

European journal of neurology·2020
Same author

White Matter Disease and Outcomes of Mechanical Thrombectomy for Acute Ischemic Stroke.

AJNR. American journal of neuroradiology·2020
Same author

Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial.

European journal of neurology·2020
Same author

Qualitative Assessment and Reporting Quality of Intracranial Vessel Wall MR Imaging Studies: A Systematic Review.

AJNR. American journal of neuroradiology·2019
Same author

Aspirin in stroke prevention.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Red Blood Cell Distribution Width is Associated with Poor Clinical Outcome After Subarachnoid Hemorrhage: A Pilot Study.

Neurocritical care·2015
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Area of Science:

  • Neurology
  • Emergency Medicine

Background:

  • Acute ischemic stroke is a time-sensitive neurological emergency.
  • Prompt evaluation and treatment are critical for patient outcomes.
  • Established protocols and specialized stroke teams expedite care.

Purpose of the Study:

  • To review the critical time windows for stroke interventions.
  • To discuss the benefits of thrombolytic therapy and emerging strategies.
  • To highlight the evolving role of traditional therapies in acute stroke management.

Main Methods:

  • Review of current clinical guidelines and recent major clinical trials.
  • Analysis of hyperacute treatment strategies for ischemic stroke.
  • Evaluation of the efficacy of reperfusion and neuroprotection.

Related Experiment Videos

Main Results:

  • Thrombolytic therapy provides significant benefits when initiated within 3 hours of stroke onset.
  • Emerging reperfusion and neuroprotection strategies require prompt initiation.
  • Recent trials have clarified the roles of antiplatelet agents and anticoagulants.

Conclusions:

  • Ultra-rapid intervention is paramount in managing acute ischemic stroke.
  • Optimized stroke protocols enhance the delivery of time-sensitive therapies.
  • A combination of established and novel treatments is essential for improving stroke patient outcomes.